Recent Security Class Actions

Mylan N.V. (NASDAQ: MYL)

Company Name:Mylan N.V.
Stock Symbol:NASDAQ: MYL
Class Period Start:02/16/2016
Class Period End (inclusive):05/07/2019
Filing Deadline:08/25/2020

According to the Complaint, Mylan N.V. is the second largest generic drug manufacturer in the world with roughly 55 manufacturing and R&D facilities globally. Mylan’s largest U.S. manufacturing facility is located in Morgantown, West Virginia. At the start of the Class Period, the facility manufactured approximately 17 billion doses of medication every year, comprising 85% of all medicine Mylan sold in the United States in 2016.